Effect of evidence ‐based cardiac drug therapy on mortality in patients with acute coronary syndrome: Findings from the Gulf COAST registry

ConclusionsAmong patients discharged after an ACS event, concurrent EBM prescribing was associated with lower all ‐cause mortality that persists for up to 12‐months posthospital discharge. The relative benefits of EBMs were also consistent across age, GRACE risk score, and discharge diagnosis.

Source: Cardiovascular Therapeutics - January 28, 2019 Category: Cardiology Authors: Ibrahim Al ‐Zakwani, Mohammad Zubaid, Alawi A. Alsheikh‐Ali, Wael Almahmeed, Wafa Rashed Tags: ORIGINAL RESEARCH ARTICLE Source Type: research